14th World Congress in Fetal Medicine Crete 2015

Transcription

14th World Congress in Fetal Medicine
Crete 2015
DIAMOND SPONSOR
CLEAR ANSWERS TO QUESTIONS THAT MATTER
Why Choose HARMONY?
The Harmony Prenatal Test is a cell-free DNA based blood test which screens for trisomies 21 (Down syndrome),
18, and 13 from as early as 10 weeks of pregnancy.
CLEAR ANSWERS TO QUESTIONS THAT MATTER
Why Choose HARMONY?
The Harmony Prenatal Test is a cell-free DNA based blood test which screens for trisomies 21 (Down syndrome),
18, and 13 from as early as 10 weeks of pregnancy.
VISIT BOOTH 1
• Unsurpassed accuracy for any age or risk
o Blinded studies in over 22,000 women of all ages
o Less than 0.1% false-positive rate for trisomy 21
• Most widely used test—in over 400,000 pregnancies and 100 countries
• Performed as early as 10 weeks
• May minimize invasive procedures caused by false-positive results
VISIT BOOTH 1
For further information regarding the benefits of the Harmony Prenatal Test, please contact us at
1-855-927-4672 or +1 925-854-6246 outside the USA, or visit our website at harmonytest.com
• Unsurpassed accuracy for any age or risk
o Blinded studies in over 22,000 women of all ages
o Less than 0.1% false-positive rate for trisomy 21
• Most widely used test—in over 400,000 pregnancies and 100 countries
• Performed as early as 10 weeks
© 2015 Ariosa Diagnostics, Inc. All Rights Reserved. ARIOSA, the Ariosa Logo, ARIOSA DIAGNOSTICS, the Ariosa Diagnostics Logo, and
HARMONY are trademarks or registered trademarks of Ariosa Diagnostics, Inc. in the U.S.A. and other countries. All other trademarks are
• May minimize
procedures
caused by false-positive results
the invasive
property of their
respective owners.
14th World Congress in Fetal Medicine
st
Sunday 21 June 2015 Joint session with the IFMSS
09:10 - 10:40
10:40 - 11:00
11.30 - 13:30
15:00 - 16:06
16:06 - 16:40
16:40 - 17:00
17:30 - 18:42
18:42 - 19:00
19:00 - 19:15
19:15 - 19:20
19:20 - 19:40
19:40 - 20:00
21:00 - 24:00
Fetal surgery for congenital diaphragmatic hernia
Pregnancy after uterine transplantation
Fetal surgery for open spina bifida
Fetal cardiac interventions
Fetal thoracic interventions
Chemotherapy in pregnancy
New therapies and imaging modalities
Neurosurgical planning and navigation
CMV: results of CYMBAL trial of valaciclovir
CMV: Pharmakokinetics of immunoglobulin therapy
Microbiome and pregnancy complications
The artificial placenta
Welcome party
nd
Monday 22 June 2015 Joint session with the IFMSS
08:00 - 09:00
09:00 - 11:00
11:30 - 12:00
12:00 - 20:00
Fetal echocardiography course
Complications of monochorionic twins
In utero cell therapy
Screening and diagnosis of chromosomal abnormalities
rd
Tuesday 23 June 2015
09:00 - 12:40
12:40 - 12:50
12:50 - 13:05
16:00 - 18:40
18:40 - 19:00
21:00 - 03:00
Impaired placentation - FGR
Functional imaging of the human placenta
Maternal gene therapy to improve fetal growth
Impaired placentation – PE
Gynecological scanning in pregnancy
Dinner party
th
Wednesday 24 June 2015
09:00 - 10:20
10:20 - 10:35
10:35 - 10:48
10:48 - 11:00
11:30 - 13:15
15.10 - 16:30
18:00 - 20:00
Gestational diabetes / fetal macrosomia
Prevalence of severe structural abnormalities today
A cryptic congenital anomaly
Diagnosis of fetal defects at 11-13 weeks
Fetal echocardiography
Neurosonography
Preterm birth
th
Thursday 25 June 2015
09:00 - 09:10
09:10 - 09:20
09:20 - 09:35
09:35 - 09:43
09:43 - 09:50
09:50 - 10:10
10:10 - 13:00
16:00 - 23:00
New FMF software for screening of PE
Biplan modalities to assist in invasive procedures
4D fetal echocardiography
Maternal mortality
Implications of fetal echogenic bowel
Labor and delivery
PRactical Obstetric Multi Professional Training
Trip to Knossos / Iraklion
DIAMOND SPONSOR
DIAMOND SPONSOR
Sunday 21st June 2015
08:00 - 09:00 Registration
Joint session with the International Fetal Medicine and Surgery Society
09:00 - 09:10
Welcome to the World Congress
Kypros Nicolaides (UK)
Jan Deprest (Belgium)
09:10 - 10:40
Fetal surgery for congenital diaphragmatic hernia (CDH)
Discussants: Alan Flake (USA), Eduard Gratacos (Spain)
09:10 - 09:22
09:22 - 09:34
09:34 - 09:42
09:42 - 09:50
09:50 - 09:58
09:58 - 10:06
10:06 - 10:14
10:14 - 10:22
10:22 - 10:30
10:30 - 10:38
CDH: postnatal outcome
CDH: prenatal management
CDH: TOTAL trial
CDH: prediction of outcome by ultrasound
CDH: meta-analysis for prediction of pulmonary hypertension
FETO: 3 year experience
CDH: MRI findings after FETO
CDH: whole transcriptome analysis after TO
CDH: trans-placental sildenafil
CDH: intra-tracheal VEGF
Francois Luks (USA)
Phillip DeKoninck (Australia)
Nicolas Sananes (USA)
Francesca Russo (Italy)
Isabella Fabietti (Italy)
Patrice Eastwood (UK)
Alexander Engels (Germany)
Stavros Loukogeorgakis (UK)
10:40 - 11:00
Pregnancy after uterine transplantation
Mats Brännström (Sweden)
11:00 - 11:30 Coffee break
11.30 - 13:30
Fetal surgery for open spina bifida (OSB)
Discussants: Martin Meuli (Switzerland), Mark Johnson (USA), Scott Adzick (USA)
11:30 - 11:40
11:40 - 11:55
11:55 - 12:10
12:10 - 12:15
12:15 - 12:20
12:20 - 12:30
12:30 - 12:35
12:35 - 12:50
12:50 - 12:58
12:58 - 13:06
13.06 - 13:30
13:06 - 13:14
13:14 - 13:22
13:22 - 13:30
OSB: prenatal diagnosis by ultrasound
OSB: prenatal assessment by MRI
OSB: outcome after open fetal surgery
OSB: obstetrical outcome after open fetal surgery
OSB: technique for fetoscopic surgery
OSB: outcome after fetoscopic surgery
OSB: outcome after mini-hysterotomy
OSB: Debate on method of surgery
How to match MOMS
Patient flow since introduction of OSB surgery
OSB: translational research
Cell spheroid based tissue engineering
Umbilical cord-patch material for SB repair
Trans-amniotic stem cell therapy
14:00 - 15:00 Lunch break
15:00 - 16:06
Fetal cardiac interventions
Discussants: Rabih Chaoui (Germany), Wolfgang Arzt (Austria)
15:00 - 15:12
15:12 - 15:25
15:25 - 15:33
15:33 - 15:48
15:48 - 15:53
15:53 - 15:58
15:58 - 16:06
Prenatal diagnosis of aortic and pulmonary stenosis
MRI imaging of the heart
5, 4, 3, 2, 1: embryological variants of pentalogy of Cantrell
Fetal interventions for congenital cardiac malformations
Fetal cardiac surgery: experience from France
Fetal cardiac surgery: experience from Poland
Discussion
16:06 - 16:40
Fetal thoracic interventions
Discussants: Greg Ryan (Canada), Dick Oepkes (Netherlands)
16:06 - 16:16
16:16 - 16:24
16:24 - 16:32
16:32 - 16:40
CPAM: open fetal surgery
CPAM: maternal corticosteroids
Shunting for hydrothorax: neonatal outcome
Thoracocentesis for severe hydrothorax
Scott Adzick (USA)
Mark Johnson (USA)
Ruben Witlox (Netherlands)
Venu Jain (Canada)
16:40 - 17:00
Chemotherapy in pregnancy
Frederic Amant (Belgium)
Rabih Chaoui (Germany)
Gregor Kasprian (Austria)
Scott Adzick (USA)
Mark Johnson (USA)
Yinka Olutoye (USA)
Denise Pedreira (Brazil)
Fabio Peralta (Brazil)
Uhli Moehrlen (Switzerland)
Tim Van Mieghem (Belgium)
Miho Watanabe (USA)
Ramesh Pappana (USA)
Beatrice Dionigi (USA)
Vita Zidere (UK)
Kuberan Pushparajah (UK)
Bhavika Kaul (USA)
Wolfgang Arzt (Austria)
Julien Stirnemann (France)
Marzena Debska (Poland)
Sunday 21st June 2015
17:30 - 18:42
New therapies and imaging modalities in fetal medicine
Discussants: Luc De Catte (Belgium), Gregor Kasprian (Austria)
17:30 - 17:38
17:38 - 17:46
17:46 - 17:54
17:54 - 18:02
18:02 - 18:10
18:10 - 18:18
18:18 - 18:26
18:26 - 18:34
18:34 - 18:42
Gastroschisis: outcome after planned preterm delivery
Gastroschisis: prenatal predictors of neonatal outcome
LUTO: outcome after cystoscopic ablation of PUVs
Fetal goiter size: sequential amniotic fluid thyroid hormone
Lung texture analysis to predict neonatal respiratory morbidity
3D image reconstruction in fetal surgery planning
MRI in assessment of Hct and SaO2 in fetal blood
US and MRI for follow up after death of a twin
Mind the gap
Carmen Mesas Burgos (Sweden)
Roopali Donepudi (USA)
Mark Evans (USA)
Eduard Gratacos (Spain)
Rosalind Pratt (UK)
Mark Osmond (Canada)
Anne-Maude Morency (Canada)
18:42 - 19:00
19:00 - 19:15
19:15 - 19:20
19:20 - 19:40
19:40 - 20:00
Neurosurgical planning and navigation
CMV: results of CYMBAL trial of valaciclovir
CMV: Pharmakokinetics of immunoglobulin therapy
Microbiome and pregnancy complications
The artificial placenta
Sebastien Ourselin (UK)
Yves Ville (France)
Oliver Kagan (Germany)
Elaine Holmes (UK)
Alan Flake (USA)
21:00 - 24:00 Welcome party
DIAMOND SPONSOR
Invites you to the lectures:
Invites you to the lectures:
“Biplan modalities to assist in invasive procedures”
“ 3D US in the diagnosis of fetal defects”
Speaker: Yves Ville
Speaker: Bernard Benoit
Time: 09:10 – 09:20 Date: Thursday, 25th of June
st
Time: 14:30-15:00 Date:
& Tuesday, 1 of July
&
“4D fetal echocardiography”
“ 2D high definition linear
probe
in the
1st and 2nd trimesters”
Speaker:
Rabih
Chaoui
Speaker:
Rabih
Chaoui25th of June
Time: 09:20
– 09:35 Date:
Thursday,
PLATINUM SPONSOR
Empowering informed choices
that can change lives.
Genomic solutions
in reproductive and
genetic health.
Illumina® is a trusted leader in innovative,
accurate genomic technologies and now
offers a comprehensive portfolio of genetic
solutions to improve options in reproductive
and genetic health.
From preimplantation genetic screening
(PGS) and preimplantation genetic
diagnosis (PGD) to Non-invasive Prenatal
Testing (NIPT), Cytogenetics, and Inherited
Condition Screening, Illumina offers a range
of solutions across the care continuum.
Learn more about how our industry-leading,
next-generation sequencing (NGS) and
microarray technologies deliver reliable,
accurate information that can guide choices
and transform lives.
Visit www.illumina.com/rgh
to learn more.
© 2014 Illumina, Inc. All rights reserved.
PLATINUM SPONSOR
The most accurate non-invasive prenatal testing from fetal DNA
Avoid the risk of amniocentesis
CE-IVD Certified
Leave me alone
I don’t like needles
Swiss Biotechnology
a company
of esperite
ww w.genoma.com
Monday 22nd June 2015
08:00 - 09:00 Fetal echocardiography course
Presenters: Vita Zidere, Kuberan Pushparajah (UK)
08:00 - 08:40 08:40 - 09:00 Systemic and pulmonary vein abnormalities
Asymmetry of the fetal heart
09:00 - 11:00
Complications of monochorionic twins
Discussants: Kurt Hecher (Germany), Liesbeth Lewi (Belgium), Ken Moise (USA)
09:00 - 09:08
09:08 - 09:16
09:16 - 09:24
09:24 - 09:32
09:32 - 09:40
09:40 - 09:48
09:48 - 09:56
09:56 - 10:04
10:04 - 10:12
10:12 - 10:20
10:20 - 10:28
10:28 - 10:38
10:38 - 10:48
10:48 - 11:00
TTTS: prediction of neonatal morbidity
TTTS: nature of neonatal morbidity
TTTS: impact of surgical techniques on prognosis
TTTS: risk of donor death
TTTS: postoperative recurrent TTTS and TAPS
TTTS: laser surgery and fetal cardiac longitudinal motion
TTTS: recipient umbilical artery elongation
TTTS: neurodevelopment after laser surgery
TTTS: impact of screening on staging at presentation
TTTS: outcome after laser surgery in triplets
RFA: effect of starting power and fetal presentation
sFGR: expectant management
sFGR: active management
sFGR: debate
11:30 - 12:00
In utero cell therapy
Discussants: Alan Flake (USA), Anna David (UK)
11:30 - 11:38
11:38 - 11:46
11:46 - 11:54
11:54 - 12:02
Enhanced engraftment of hematopoietic stem cells Hematopoietic engraftment of amniotic fluid stem cells
Trans-amniotic stem cell therapy in gastroschisis
Placental and umbilical cord blood stem cells in preeclampsia
12:00 - 20:00
Discussants: Kypros Nicolaides (UK), Yves Ville (France), Howard Cuckle (Israel)
12:00 - 12:15
12:15 - 12:25
12:25 - 12:35
12:35 - 12:45
12:45 - 12:52
12:52 - 13:00
13:00 - 13:08
13:08 - 13:16
13:16 - 13:30
Overview
The origin of the origin of Down syndrome
Implications of fetoplacental mosaicism
Price of abandoning invasive testing
Pathogenic CNVs in the presence of US abnormalities
Inadequacy of cfDNA test in cases of increased fetal NT Replacing FTS by cfDNA test: remaining risk for aneuploidies
Expanded carrier screening
Discussion
15:30 - 15:36
15:36 - 15:42
15:42 - 15:48
15:48 - 15:54
15:54 - 16:00
16:00 - 16:10
Screening for trisomies 21, 18, 13
Combined test: implementation in Hong Kong
Combined test: implementation in Czechia
Combined test: profile of women refusing screening
cf DNA test: factors affecting uptake
cf DNA test: impact on CVS rate and indications
Discussion
16:10 - 16:18
16:18 - 16:22
16:22 - 16:30
16:30 - 16:38
16:38 - 16:45
16:45 - 17:00
cf DNA test: clinical validation of the IONA test
cf DNA test: performance of the IONA test at 11-13 weeks
cf DNA test: clinical validation of the Veracity test
cf DNA test: clinical performance and counseling
cf DNA test: positive predictive value
Discussion
Yves Ville (France)
Enrico Lopriore (Netherlands)
Saul Snowise (USA)
Fatima Crispi (Spain)
Jeanine van Klink (Netherlands)
Asma Khalil (UK)
Mark Johnson (USA)
Liesbeth Lewi (Belgium)
Camila Fachin (USA)
Christina Feng (USA)
Zahra Masoumi (Sweden)
Eugene Pergament (USA)
Francesca Grati (Italy)
Mark Evans (USA)
Richard Choy (China)
Alexandra Benachi (France)
James Goldberg (USA)
Daljit Sahota (China)
Pavel Calda (Czechia)
Hanne Trap Wolf (Denmark)
Nerea Maiz (Spain)
Stefan Kane (Australia)
Brenda Kelly (UK)
Liona Poon (UK)
George Koumbaris (Cyprus)
Kirsten Curnow (USA)
Tak Yeung Leung (China)
Monday 22nd June 2015
17:30 - 20:00
Discussants: Kypros Nicolaides (UK), Yves Ville (France), Howard Cuckle (Israel)
17:30 - 17:36 17:36 - 17:40 17:40 - 17:46 17:46 - 17:52 17:52 - 18:05 cf DNA test: Management of failed result
Factors affecting fetal fraction Differences in estimates from different laboratories Fetal-fraction based risk and redraw success Low fetal fraction: results of samples after redraw Discussion
Fabricio Costa (Australia)
Jacques Jani (Belgium)
Allison Ryan (USA)
Thomas Musci (USA)
18:05 - 18:15
18:15 - 18:25
18:25 - 18:30
18:30 - 18:35
18:35 - 18:40
18:40 - 18:55
cf DNA test: Clinical implementation
NEXT study
UK NHS study
Copenhagen study
Italian study
cf DNA test: screening in twins
Discussion
Thomas Musci (USA)
Mar Gil (UK)
Caroline Borregaard (Denmark)
Nicola Persico (Italy)
18:55 - 19:00
19:00 - 19:10
cf DNA test: Screening for sex chromosome aneuploidies
cf DNA test: results from the Danish study
Discussion
Ann Tabor (Denmark)
19:10 - 19:20
19:20 - 19:30
19:30 - 19:40
19:40 - 19:50
19:50 - 20:00
Screening by cf DNA for microdeletions
Prevalence of pathogenic microdeletions / microduplications
cf DNA test: screening for 22q11.2 deletion syndrome
cf DNA test: screening for microdeletions / microduplications
cf DNA test: e karyotyping
Discussion
Susan Gross (USA)
Mathias Ehrich (USA)
Frederic Amar (Switzerland)
Fetal and neonatal medicine from
basic research to clinical practice
More information
on the journal websites:
Original Papers
241 Prediction of Respiratory Outcome in Extremely Low
Gestational Age Infants
Parad, R.B.; Davis, J.M. (Boston, Mass.); Lo, J.; Thomas, M.;
Marlow, N.; Calvert, S.; Peacock, J.L.; Greenough, A.
(London)
249 Ketamine Attenuates the ACTH Response to Hypoxia
in Late-Gestation Ovine Fetus
Chang, E.I.; Wood, C.E. (Gainesville, Fla.)
258 Perfusion Index in Preterm Infants during the First
or: 2.295
Impact fact
3 Days of Life: Reference Values and Relation with
Clinical Variables
Alderliesten, T.; Lemmers, P.M.A.; Baerts, W.; Groenendaal,
F.; van Bel, F. (Utrecht)
271 Cost Savings of Human Milk as a Strategy to Reduce
the Incidence of Necrotizing Enterocolitis in Very Low
Birth Weight Infants
Johnson, T.J.; Patel, A.L.; Bigger, H.R.; Engstrom, J.L.;
Meier, P.P. (Chicago, Ill.)
277 Lung Deposition of Nebulized Surfactant in Newborn
Piglets
Linner, R.; Perez-de-Sa, V.; Cunha-Goncalves, D. (Lund)
289 Neuro-Imaging Findings in Infants with Congenital
Cytomegalovirus Infection: Relation to Trimester of
Infection
Oosterom, N.; Nijman, J.; Gunkel, J.; Wolfs, T.F.W.;
Groenendaal, F.; Verboon-Maciolek, M.A.; de Vries, L.S.
(Utrecht)
297 Infant Arterial Stiffness and Maternal Iron Status in
Pregnancy: A UK Birth Cohort (Baby VIP Study)
Alwan, N.A.; Cade, J.E. (Leeds); McArdle, H.J. (Aberdeen);
Greenwood, D.C. (Leeds); Hayes, H.E. (Aberdeen); Ciantar,
E.; Simpson, N.A.B. (Leeds)
304 CXCR4 Blockade Attenuates Hyperoxia-Induced Lung
Injury in Neonatal Rats
Drummond, S.; Ramachandran,
or: 2.369
S.; Torres, E.; Huang, J.;
Hehre, D.; Suguihara, C.; Young, K.C. (Miami, Fla.)
Impact fact
Short Communication
266 Phase Changing Material: An Alternative Method for
Cooling Babies with Hypoxic Ischaemic
Encephalopathy
Thomas, N.; Chakrapani, Y.; Rebekah, G.; Kareti, K.;
Devasahayam, S. (Vellore)
283 Using Measurements of Shunt and Ventilation-to-
Perfusion Ratio to Quantify the Severity of
Bronchopulmonary Dysplasia
Dassios, T.; Curley, A.; Morley, C.; Ross-Russell, R.
(Cambridge)
(Continued on inside front cover)
International
gs of the 30th
Includes ProceedinSurfactant Replacement
Workshop on
5–6, 2015
Stockholm, June
www.karger.com/fdt
www.karger.com/neo
Editor-in-Chief
Editors-in-Chief
E. Gratacós, Barcelona
H.L. Halliday, Belfast
C.P. Speer, Würzburg
Fetal Diagnosis and Therapy
2015: Volumes 36, 37
4 issues per volume
Language: English
ISSN 1015–3837 (print)
ISSN 1421–9964 (online)
Neonatology
2015: Volumes 107, 108
4 issues per volume
Language: English
ISSN 1661–7800 (print)
ISSN 1661–7819 (online)
• Pay-per-View and
Subscriber Access to Full Text
• Full Table of Contents
• Full Editorial Board
• Free Abstracts and Selected Articles
• Online Sample Issue
• Submission/Guidelines for Authors
• Subscription Details
• Free Alert Service
• Online Library Recommendation
Listed in bibliographic services, including
Current Contents®, MEDLINE, Biological Abstracts,
EMBASE/Excerpta Medica
KI15393
Fetal and Neonatal Research
GOLD SPONSOR
GOLD SPONSOR
A new advanced Non-Invasive Prenatal
Test (NIPT) for Down’s syndrome and
other serious genetic conditions.
Allowing pregnant women fast, reliable
results and reducing the need for
invasive tests and the associated stress
and anxiety.
The IONA® test is for pregnant women to estimate
the probability that their fetus is affected with:
• Trisomy 21 (Down’s syndrome)
• Trisomy 18 (Edwards’ syndrome)
• Trisomy 13 (Patau’s syndrome)
Please come and visit us at our booth at
the 14th World Congress in Fetal Medicine
www.premaitha.com
Key features of the IONA® test:
CE-IVD NIPT which allows local screening
for pregnant women
Results available in 3-5 days
Analyses cell-free fetal DNA from a sample
of maternal blood
>99% detection and <1% false positive rate
Includes IONA® Software for analysis
Generates easy to interpret results
For more information:
Email: iona@premaitha.com
Tel: +44(0)161 667 6865
Tuesday 23rd June 2015
09:00 - 12:40
Impaired placentation - FGR
Discussants: Gerry Visser (Netherlands), Eduard Gratacos (Spain)
09:00 - 09:15
09:15 - 09:30
09:30 - 09:45
09:45 - 10:00
10:00 - 10:15
10:15 - 10:30
10:30 - 10:45
10:45 - 11:00
Overview
Implications of TRUFFLE study
Placental findings in impaired placentation
Placental vs non-placental late SGA
FGR: does size matter?
SGA: timing of 3rd trimester scan
Prediction of adverse perinatal outcome
Discussion
11:30 - 11:38
11:38 - 11:46
11:46 - 11:54
11:54 - 12:02
12:02 - 12:10
12:10 - 12:18
12:18 - 12:26
12:26 - 12:34
12:34 - 12:40
FGR: placental expression of PAPPA, PAPPA-2 and PLAC-1
FGR: circulating and myometrial markers of oxidative stress
FGR: environmental enrichment and neurodevelopment
FGR: effect of steroids on fetal circulation
FGR: prediction by placental vascular biopsy
FGR: prediction by biomarkers in the 1st trimester
Reproducibility of TV / TA 1st trimester uterine artery PI
FGR: prediction by angiogenic factors in the 3rd trimester
Discussion
Stavros Sifakis (Greece)
Ayse Kirbas (Turkey)
Miriam Illa (Spain)
Laura Marchi (Netherlands)
Cahit Birdir (Germany)
Francesca Crovetto (Spain)
Anthony Odibo (USA)
12:40 - 12:50
Functional imaging of the human placenta
Laurent Salomon (France)
12:50 - 13:05
Maternal gene therapy to improve fetal growth
Anna David (UK)
16:00 - 18:40
Impaired placentation – PE
Discussants: Gerry Visser (Netherlands), Kypros Nicolaides (UK)
16:00 - 16:08
16:08 - 16:16
16:16 - 16:24
16:24 - 16:40
16:40 - 16:55
2nd trimester prediction of stillbirth
Reduced fetal movements at term
Perinatal loss in twins: fetal biometry and Doppler
Investigation of stillbirth
PE: not a placental disorder
17:30 - 17:38
17:38 - 17:45
17:45 - 18:00
18:00 - 18:08
18:08 - 18:16
18:16 - 18:24
18:24 - 18:32
18:32 - 18:40
PE: 1st trimester maternal immunological profile
PE: prediction by sFlt-1 in the 2nd and 3rd trimesters
PE: competing risk model
PE in twins: effect of chorionicity
PE in twins: 1st trimester prediction
PE in twins: prediction by sFlt-1 / PlGF
Prevention of PE / FGR: impact of aspirin dose
Prevention of PE: RCT of aspirin 80 vs 160 mg
Mauro Para-Cordero (Chile)
Dahiana Gallo (UK)
David Wright (UK)
Katrine Vasehus Schou (Denmark)
Ran Svirsky (Israel)
Jesus Rodriguez Calvo (Spain)
Stephanie Roberge (Canada)
Emmanuel Bujold (Canada)
18:40 - 19:00
Gynecological scanning in pregnancy
Dimitris Mavrelos (UK)
21:00 - 03:00 Dinner party
Gerry Visser (Netherlands)
Kurt Hecher (Germany)
Neil Sebire (UK)
Basky Thialaganathan (UK)
Liona Poon (UK)
Ranjit Akolekar (UK)
Alessandra Familiari (UK)
Carolina Scala (UK)
Asma Khalil (UK)
Neil Sebire (UK)
SILVER SPONSOR
Understanding Pregnancy Care
Complete solution from
early gestation until delivery
Broad Elecsys® menu for pregnancy testing
• Preeclampsia
• Down Syndrome screening
• TORCH group infections
• Thyroid hormones
• Other tests for pregnant women
(infectious diseases, Vitamin D, anemia, …)
Proven clinical and technical performance
for a better maternal and fetal care.
COBAS, ELECSYS and LIFE NEEDS ANSWERS are trademarks of Roche.
©2014 Roche · Roche Diagnostics International Ltd · CH-6343 Rotkreuz · Switzerland · www.cobas.com
SILVER SPONSOR
REVOLUTIONIZING PRENATAL CARE
NONINVASIVE PRENATAL
TESTING OPTIONS FOR ALL
Noninvasive prenatal testing (NIPT) was pioneered by Sequenom
Laboratories in 2011, and since then, several hundred thousand
pregnant women worldwide have benefited. Many have avoided
potentially unnecessary invasive procedures while still gaining
important information about the health of their pregnancies.
Stop by our booth to learn more about the MaterniT21® PLUS
and VisibiliT™ laboratory-developed tests, and to see what’s next.
Sequenom Laboratories is proud to be a Silver Sponsor of
the Fetal Medicine Foundation Meeting, June 21-25, 2015.
Email: info@sequenom.com Web: www.sequenom.com/laboratories
Wednesday 24th June 2015
09:00 - 10:20
Gestational diabetes / fetal macrosomia
Discussants: Gerry Visser (Netherlands), John Hyett (Australia)
09:00 - 09:12
09:12 - 09:20
09:20 - 09:28
09:28 - 09:43
09:43 - 09:55
09:55 - 10:07
10:07 - 10:20
Lifestyle intervention in obese pregnancies
Vaginal birth: BW and adverse outcome
Amniotic fluid metabolic variations by NMRomics
Metformin for treatment of diabetes and metabolic syndrome
1st trimester prediction of GDM
Obesity in pregnancy: RCT of metformin treatment
Challenges in GDM
Eugene Oteng (UK)
Eran Ashwal (Israel)
Apostolos Athanasiadis (Greece)
Hassan Shehata (UK)
John Hyett (Australia)
Argyro Syngelaki (UK)
10:20 - 10:35
10:35 - 10:48
Prevalence of severe structural abnormalities today
A cryptic congenital anomaly
Howard Cuckle (Israel)
Reuven Achiron (Israel)
10:48 - 11:00
10:48 - 10:54
10:54 - 11:00
Diagnosis of fetal defects at 11-13 weeks
Detection of non-chromosomal defects
Always detectable 9 and much more
Prathima Radhakrishnan (India)
11:30 - 13:15
Fetal echocardiography
Discussants: Rabih Chaoui (Germany), Vita Zidere (UK)
11:30 - 11:45
11:45 - 12:00
12:00 - 12:10
12:10 - 12:16
12:16 - 12:22
12:22 - 12:28
12:28 - 12:34
12:34 - 12:40
12:40 - 12:46
12:46 - 12:52
12:52 - 12:58
12:58 - 13:04
13:04 - 13:12
First trimester diagnosis of heart defects
Fetal vascular imaging
Prenatal disease and cardiovascular remodelling
Complete AVSD at 11-13 w: abnormal flow in DV and TV
Ductus venosus agenesis: diagnosis and outcome
3VTV in screening for heart defects at 11-13 w
ARSA: association with trisomy 21
ARSA: association with aneuploidies
Right aortic arch: association with 22q11.2 deletion
Truncus versus pulmonary atresia with intact septum
Impact of prenatal diagnosis on mortality from d-TGA
Prenatal detection of coarctation of the aorta
New technologies
15.10 - 16:30
Neurosonography
Discussants Rabih Chaoui (Germany), Katia Bilardo (Netherlands)
15:10 - 15:25
15:25 - 15:33
15:33 - 15:41
15:41 - 15:49
15:49 - 15:57
15:57 - 16:05
16:05 - 16:13
16:13 - 16:21
16:21 - 16:29
Overview
Abnormal posterior brain at 11 - 13 w
Virtual autopsy of the early fetal brain
Corpus callosum in fetuses with heart defects
Conus medullaris in spina bifida
Isolated mild ventriculomegaly
Guideline on acquisition of brain volumes
CNS defects: evaluation by MRI and US fusion imaging
CNS defects: diagnosis in the third-trimester
18:00 - 20:00
Preterm birth
Discussants: Zarko Alfirevic (UK), Kypros Nicolaides (UK)
18:00 - 18:20
18:20 - 18:30
18:30 - 18:40
18:40 - 18:50
18:50 - 18:57
18:57 - 19:04
19:04 - 19:11
19:11 - 19:18
19:18 - 19:25
19:25 - 19:32
19:32 - 19:40
19:40 - 20:00
Overview on strategies for prediction and prevention
Discussion
Tocolytics and corticosteroids
Threatened PTB: PECEP-RETARD Trial
Cervical cerclage in twins
Short cervix : effect of long-term indomethacin
PTB: prediction by circulating RNA markers
PTB: prediction by mid trimester cervical length
PTB: cervical microbiome signature
PTB: amniotic fluid pro-inflammatory biomarkers
PPROM in twins: interval to delivery
Discussion
Georgios Rembouskos (Italy)
Brunella Muto (Italy)
Valentina De Robertis (Italy)
Mar Bennasar (Spain)
Angela Ranzini (Belgium)
Nicola Volpe (Italy)
Hedwig vd Nieuwenhof (Netherlands)
Jader Cruz (Portugal)
Tiziana Fanelli (Italy)
Claudio Lombardi (Italy)
Carlos Montefusco Pereira (Spain)
Denise Pugash (Canada)
Elisenda Eixarch (Spain)
Nerea Maiz (Spain)
Bart De Keersmaecker (Belgium)
Eldad Katorza (Israel)
Zarko Alfirevic (UK)
Elena Carreras (Spain)
Edwin Guzman (USA)
Ozhan Turan (USA)
Stephen Chim (China)
Athena Souka (Greece)
Meng Meng (China)
BRONZE SPONSOR
20150508_Ad_sFlt-1_FMF140x50mm_2015_RZ_Layout 1 12.06.15 09:49 Seite 1
PNS on KRYPTOR
Exceptional precision and sensitivity
Complete portfolio for first trimester screening and
pre-eclampsia management throughout pregnancy
hCG+β
PAPP-A
Free βhCG
AFP
sFlt-1
PlGF
uE3 coming soon
thermoscientific.com/brahms
© 2015 Thermo Fisher Scientific Inc. All rights reserved. KRYPTOR is a registered trademark of CIS bio international, licensed for
use by B·R·A·H·M·S, a part of Thermo Fisher Scientific. All other trademarks are the property of Thermo Fisher Scientific and its subsidiaries.
STANDARD SPONSORS
Thursday 25th June 2015
09:00 - 09:10
09:10 - 09:20
09:20 - 09:35
09:35 - 09:43
09:43 - 09:50
New FMF software for screening of PE
Biplan modalities to assist in invasive procedures
4D fetal echocardiography
Maternal mortality
Implications of fetal echogenic bowel
09:50 - 10:10
Labor and delivery
Discussants: Gerry Visser (Netherlands), John Hyett (Australia)
09:50 - 09:56
09:56 - 10:02
10:02 - 10:08
ECV for breech at term
Prediction of time to delivery: elastography and Bishop Score
Prediction of success of labor induction: fetal adrenal gland
10:10 - 13:00
PRactical Obstetric Multi Professional Training (PROMPT)
Moderator: Carl Weiner (USA)
10:10 - 10:15
10:15 - 10:30
10:30 - 10:45
10:45 - 11:00
Introduction
Why PROMPT
PROMPT is exportable to high and low resource countries
Maternal collapse
11:30 - 11:45
11:45 - 12:00
12:00 - 12:15
12:15 - 12:30
12:30 - 13:00
Shoulder dystocia
Maternal hemorrhage
Hypertensive emergencies
Maternal sepsis
Structuring local training and simulation scenarios / Questions
16:00 - 23:00 Trip to Knossos / Iraklion
Yves Ville (France)
Yaprak Engin-Üstün (Turkey)
Mireille Bekker (Netherlands)
Breffini Anglim (Ireland)
Krzysztof Preis (Poland)
Ozhan Turan (USA)
Carl Weiner (USA)
Dimitrios Siassakos (UK)
Carl Weiner (USA)
Neil Muchatuta (UK)
Carl Weiner (USA)
Neil Muchatuta (UK)
Christine Burden (UK)
Michelle Schulz (USA)
Advances in Fetal Medicine Course
5 – 6 December 2015
London
Registration will open in August 2015
Limited Number of places
Registration fee is £150, which includes lunches and coffees
Speakers:
Scott Adzick (USA)
Ranjit Akolekar (UK)
Zarko Alfirevic (UK)
Frederic Amant (Belgium)
Frederic Amar (Switzerland)
Breffini Anglim (Ireland)
Wolfgang Arzt (Austria)
Eran Ashwal (Israel)
Apostolos Athanasiadis (Greece)
Mireille Bekker (Netherlands)
Alexandra Benachi (France)
Cahit Birdir (Germany)
Caroline Borregaard (Denmark)
Mats Brännström (Sweden)
Christine Burden (UK)
Pavel Calda (Czechia)
Elena Carreras (Spain)
Stephen Chim (China)
Richard Choy (China)
Fabricio Costa (Australia)
Francesca Crovetto (Spain)
Jader Cruz (Portugal)
Howard Cuckle (Israel)
Kirsten Curnow (USA)
Anna David (UK)
Bart De Keersmaecker (Belgium)
Valentina De Robertis (Italy)
Marzena Debska (Poland)
Phillip DeKoninck (Australia)
Beatrice Dionigi (USA)
Patrice Eastwood (UK)
Mathias Ehrich (USA)
Elisenda Eixarch (Spain)
Alexander Engels (Germany)
Yaprak Engin-Üstün (Turkey)
Mark Evans (USA)
Isabelle Fabietti (Italy)
Camila Fachin (USA)
Alessandra Familiari (UK)
Tiziana Fanelli (Italy)
Christina Feng (USA)
Alan Flake (USA)
Dahiana Gallo (UK)
Mar Gil (UK)
James Goldberg (USA)
Susan Gross (USA)
Edwin Guzman (USA)
Kurt Hecher (Germany)
Elaine Holmes (UK)
John Hyett (Australia)
Miriam Illa (Spain)
Venu Jain (Canada)
Mark Johnson (USA)
Stefan Kane (Australia)
Gregor Kasprian (Austria)
Eldad Katorza (Israel)
Bhavika Kaul (USA)
Brenda Kelly (UK)
Asma Khalil (UK)
Ayse Kirbas (Turkey)
George Koumbaris (Cyprus)
Tak Yeung Leung (China)
Liesbeth Lewi (Belgium)
Claudio Lombardi (Italy)
Enrico Lopriore (Netherlands)
Francois Luks (USA)
Nerea Maiz (Spain)
Zahra Masoumi (Sweden)
Dimitris Mavrelos (UK)
Meng Meng (China)
Carmen Mesas Burgos (Sweden)
Uhli Moehrlen (Switzerland)
Carlos Montefusco Pereira (Spain)
Anne-Maude Morency (Canada)
Neil Muchatuta (UK)
Thomas Musci (USA)
Brunella Muto (Italy)
Anthony Odibo (USA)
Yinka Olutoye (USA)
Eugene Oteng (UK)
Sebastien Ourselin (UK)
Ramesh Pappana (USA)
Mauro Para-Cordero (Chile)
Denise Pedreira (Brazil)
Fabio Peralta (Brazil)
Eugene Pergament (USA)
Nicola Persico (Italy)
Liona Poon (UK)
Rosalind Pratt (UK)
Krzysztof Preis (Poland)
Denise Pugash (Canada)
Kuberan Pushparajah (UK)
Prathima Radhakrishnan (India)
Angela Ranzini (Belgium)
Georgios Rembouskos (Italy)
Stephanie Roberge (Canada)
Allison Ryan (USA)
Daljit Sahota (China)
Laurent Salomon (France)
Carolina Scala (UK)
Michelle Schulz (USA)
Neil Sebire (UK)
Hassan Shehata (UK)
Stavros Sifakis (Greece)
Saul Snowise (USA)
Athena Souka (Greece)
Ran Svirsky (Israel)
Argyro Syngelaki (UK)
Ann Tabor (Denmark)
Hanne Trap Wolf (Denmark)
Ozhan Turan (USA)
Jeanine van Klink (Netherlands)
Tim Van Mieghem (Belgium)
Katrine Vasehus Schou (Denmark)
Hedwig vd Nieuwenhof (Netherlands)
Yves Ville (France)
Nicola Volpe (Italy)
Miho Watanabe (USA)
Carl Weiner (USA)
Ruben Witlox (Netherlands)
David Wright (UK)
Vita Zidere (UK)
The Fetal Medicine Foundation
UK Charity Number 1037116
137 Harley Street, London, W1G 6BG, UK
Tel: +44 (0) 207 034 3070
www.fetalmedicine.com

14th World Congress in Fetal Medicine Crete 2015

Transcription

Similar documents

could abnormal fetal movements be a clue to the prenatal diagnosis

Labor and delivery consumables brochure

Fetal Alcohol Syndrome Fetal Alcohol Syndrome

Society for Theriogenology www.therio.org

fisiologi sirkulasi fetus - Repository Universitas Andalas

Avalon CL – A moving birth experience - InCenter

2013